VVOS – vivos therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Vivos Therapeutics, Inc. (VVOS) Discusses Strategic Business Model Pivot and Transition in Sleep Apnea Treatment Approach Transcript [Seeking Alpha]
Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan
Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST [Yahoo! Finance]
Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST
Vivos Therapeutics (NASDAQ:VVOS) had its price target lowered by analysts at Ascendiant Capital Markets from $6.50 to $5.50. They now have a "buy" rating on the stock.
Form 8-K Vivos Therapeutics, Inc. For: Dec 16
Form 8-K Vivos Therapeutics, Inc. For: Dec 05
Form 8-K Vivos Therapeutics, Inc. For: Nov 19
Form 10-Q Vivos Therapeutics, Inc. For: Sep 30
Form NT 10-Q Vivos Therapeutics, Inc. For: Sep 30
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.